Trifluoperazine, an Antipsychotic Agent, Inhibits Cancer Stem Cell Growth and Overcomes Drug Resistance of Lung Cancer

Chi‐Tai Yeh, Alexander T.H. Wu, Peter Mu‐Hsin Chang, +17

American Journal of Respiratory and Critical Care Medicine

Advanced non-small cell lung cancer in patients aged 45 years or younger: outcomes and prognostic factors

Chia‐Lin Hsu, Kuan‐Yu Chen, Jin‐Yuan Shih, +4

BMC Cancer

Pneumothorax in the ICU

Kuan‐Yu Chen, Jih‐Shuin Jerng, Wei‐Yu Liao, +4

CHEST Journal

PneumothoraxSepsisPleural EffusionThoracic SurgeryPleural Disease +3

Association between programmed death-ligand 1 expression, immune microenvironments, and clinical outcomes in epidermal growth factor receptor mutant lung adenocarcinoma patients treated with tyrosine kinase inhibitors

Ching‐Yao Yang, Wei‐Yu Liao, Chao‐Chi Ho, +14

European Journal of Cancer

MedicineImmunologyPathologyCell DeathBronchial Neoplasm +9

Outcome and prognostic factors in critically ill patients with systemic lupus erythematosus: a retrospective study

Chia‐Lin Hsu, Kuan‐Yu Chen, Pu-Sheng Yeh, +5

Critical Care

Clinical outcomes and secondary epidermal growth factor receptor (EGFR) T790M mutation among first‐line gefitinib, erlotinib and afatinib‐treated non‐small cell lung cancer patients with activating EGFR mutations

Yen‐Ting Lin, Jin‐Shing Chen, Wei‐Yu Liao, +9

International Journal of Cancer

Cancer ManagementPathologyGood Clinical OutcomesT790m MutationEgfr Mutations +14

Second‐line treatments after first‐line gefitinib therapy in advanced nonsmall cell lung cancer

Jenn‐Yu Wu, Jin‐Yuan Shih, James Chih‐Hsin Yang, +4

International Journal of Cancer

Gefitinib TherapyFirst‐line Gefitinib TherapyMedicineFirst-line GefitinibPathology +9

Tumor PD-L1 Expression and Clinical Outcomes in Advanced-stage Non-Small Cell Lung Cancer Patients Treated with Nivolumab or Pembrolizumab: Real-World Data in Taiwan

Shu‐Yung Lin, Ching‐Yao Yang, Bin-Chi Liao, +13

Journal of Cancer

Bcl-2-Like Protein 11 Deletion Polymorphism Predicts Survival in Advanced Non–Small-Cell Lung Cancer

Jih‐Hsiang Lee, Yulin Lin, Wei‐Hsun Hsu, +10

Journal of Thoracic Oncology

MedicineBcl-2-like Protein 11ImmunologyPathologyCancer Cell Biology +6

Development of an AlphaLISA assay to quantify serum core-fucosylated E-cadherin as a metastatic lung adenocarcinoma biomarker

Chu‐Ling Wen, Kuan‐Yu Chen, Chih-Ta Chen, +3

Journal of Proteomics

Tumor BiologySerum Core-fucosylated E-cadherinBiomarker (Medicine)Alphalisa AssayBiomarker Target +8